U.S. markets closed

Pfizer Inc. (PFE)

NYSE - NYSE Delayed Price. Currency in USD
32.09-0.01 (-0.03%)
At close: 04:00PM EDT
32.12 +0.03 (+0.09%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close32.10
Bid32.07 x 3200
Ask32.15 x 4000
Day's Range31.77 - 32.32
52 Week Range31.77 - 54.93
Avg. Volume24,088,332
Market Cap181.179B
Beta (5Y Monthly)0.55
PE Ratio (TTM)8.53
EPS (TTM)3.76
Earnings DateOct 31, 2023
Forward Dividend & Yield1.64 (5.06%)
Ex-Dividend DateJul 27, 2023
1y Target Est44.38
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
5% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for PFE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Pfizer, Inc.
    Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more